突发心脏死亡的蛋白质学概况与获得的心脏缩
Yu Kakimoto1, Atsushi Ueda2, Masatoshi Ito3
1Department of Forensic Medicine, Tokai University School of Medicine, Kanagawa, Japan. kakimoto@tokai-u.jp.
International journal of legal medicine
|June 7, 2023
概括
获得性心脏缩 (SCH) 的突然心脏死亡 (SCD) 显示出明显的蛋白质变化,特别是像MYH7和MYL3这样的瘤蛋白增加,有助于在老年人中进行死后诊断.
科学领域:
- 心脏病学 心脏病学
- 蛋白质组学是指蛋白质组学.
- 病理学 病理学 病理学
背景情况:
- 与高血压和肥胖有关的心脏缩是心脏突然死亡 (SCD) 的危险因素.
- 区分获得性心脏缩 (SCH) 和死后补偿性心脏缩 (CCH) 是一个挑战.
- 了解SCH中的蛋白质组差异对于准确的死后诊断至关重要.
研究的目的:
- 为了确定与CCH和对照组相比,SCH中的蛋白质组变化.
- 建立一个蛋白质基因指南,用于死后诊断SCH.
- 调查沙科梅尔蛋白质变化在SCD风险中的作用.
主要方法:
- 来自SCH,CCH和对照组 (40岁以上) 的解剖衍生心脏组织样本.
- 组织学检查,枪支蛋白质组分析和定量PCR.
- 排除了多变性心肌病的病例.
主要成果:
- 肥胖,心肌缩和轻度纤维化在SCH和CCH组与对照组相似.
- 与CCH和对照病例相比,在SCH病例中观察到不同的蛋白质组形状.
- 在SCH.中,瘤蛋白质含量增加,包括MYH7和MYL3 (蛋白质和mRNA),具有显著意义.
结论:
- 本研究提出了首次对SCH和CCH进行心脏蛋白质组分析.
- 萨尔科默蛋白的逐步上调可能会在获得的心脏缩时增加SCD风险.
- 这些发现可能有助于在中年和老年人中对SCH的死后诊断.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
17
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
17
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
205
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
205
Cardiomyopathy I: Introduction and Classification
23
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
23
Acute Coronary Syndrome III: Diagnostic Studies
11
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11


